Eton Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $18,928 | $17,282 | $11,647 | $10,324 |
Gross Profit | 11,924 | 9,861 | 6,476 | 6,302 |
EBITDA | -1,475 | -470 | 1,177 | 787 |
EBIT | -1,483 | 822 | 509 | |
Net Income | -2,585 | -1,572 | -598 | 627 |
Net Change In Cash | 18,928 | 17,282 | 11,647 | 10,324 |
Free Cash Flow | 7,959 | 2,090 | -8,897 | 4,820 |
Cash | 25,379 | 17,420 | 14,936 | 20,261 |
Basic Shares | 26,893 | 26,886 | 26,136 | 26,550 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $39,011 | $31,642 | $21,251 | $21,832 |
Gross Profit | 23,411 | 21,061 | 14,318 | 19,209 |
EBITDA | -1,451 | -291 | -6,486 | -1,121 |
EBIT | -2,597 | -1,192 | -8,251 | -1,495 |
Net Income | -3,823 | -936 | -9,021 | -1,955 |
Net Change In Cash | 39,011 | 31,642 | 21,251 | 21,832 |
Cost of Revenue | 1,899 | |||
Free Cash Flow | 943 | 6,040 | 2,033 | -7,980 |
Cash | 14,936 | 21,388 | 16,305 | 14,406 |
Basic Shares | 25,895 | 25,645 | 25,146 | 25,207 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.03 |
2025-03-31 | -$0.06 |
2024-12-31 | -$0.02 |
